PPD (Pharmaceutical Product Development) is a contract research organization that provides drug development services to the biopharmaceutical industry. It delivers clinical development and laboratory services to pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants.

Employee Rating

4
TypeSubsidiary
Parent CompanyThermo Fisher Scientific
HQWilmington, NC, US
Founded1985
Websiteppd.com
Cybersecurity ratingCMore
PPD was founded in 1985 and is headquartered in Wilmington, NC, US
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at PPD

Rob Petrie

Rob Petrie

Chief Technology Officer
David Johnston

David Johnston

President
Amber Lee

Amber Lee

Senior Vice President
Bhooshi de Silva

Bhooshi de Silva

Senior Vice President, Global Head, Corporate Development, Strategy and Ventures
Jon Denissen

Jon Denissen

Senior Vice President, PPD Laboratories GMP Lab
Nicole Hedrick

Nicole Hedrick

Senior Vice President, Human Resources
Show more

PPD Office Locations

PPD has offices in Wilmington, Austin, Hamilton Township, Highland Heights and in 65 other locations
Wilmington, NC, US (HQ)
PPD Building, 929 N Front St
Austin, TX, US
7551 Metro Center Dr #200
Hamilton Township, NJ, US
3575 Quakerbridge Rd
Highland Heights, KY, US
2 Tesseneer Rd
Horsham, PA, US
132 Welsh Rd
Las Vegas, NV, US
8285 W Arby Ave #331
Show all (75)

PPD Financials and Metrics

Summary Metrics

Founding Date

1985
PPD is a subsidiary of Thermo Fisher Scientific

PPD Revenue

Embed Graph
View revenue for all periods
PPD's revenue was reported to be $4.68 b in FY, 2020 which is a 16.1% increase from the previous period.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

3.7b4.0b4.7b

Revenue growth, %

25%8%16%

Cost of goods sold

1.3b1.5b1.7b

Gross profit

2.4b2.5b3.0b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

1.1b1.0b1.2b1.4b1.6b1.6b

Cost of goods sold

414.4m374.8m433.4m477.6m500.2m529.7m

Gross profit

658.0m636.1m800.4m900.8m1.1b1.0b

Gross profit Margin, %

61%63%65%65%68%66%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

553.1m345.2m768.0m

Accounts Receivable

1.3b1.3b1.6b

Prepaid Expenses

146.1m

Current Assets

1.9b1.8b2.5b
Quarterly
USDQ3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

403.4m738.4m693.0m803.1m826.4m949.0m1.2b

Accounts Receivable

1.3b1.4b1.8b2.0b2.1b

Prepaid Expenses

117.1m122.0m155.0m166.6m

Current Assets

1.9b2.2b2.2b2.4b2.8b3.2b3.4b
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

106.9m52.8m160.6m

Depreciation and Amortization

259.0m264.8m279.1m

Accounts Payable

(4.4m)26.3m141.2m

Cash From Operating Activities

423.4m432.9m251.3m
Quarterly
USDQ3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

34.5m(13.1m)49.0m58.1m47.3m98.8m267.9m

Depreciation and Amortization

197.9m66.3m135.1m206.4m73.1m153.4m227.4m

Accounts Payable

12.5m(48.1m)(22.3m)116.5m28.1m88.9m167.7m

Cash From Operating Activities

313.7m19.4m130.8m268.5m148.2m295.0m586.4m
USDFY, 2018

Debt/Equity

-3.1 x

Debt/Assets

0.9 x

Financial Leverage

-3.6 x
Show all financial metrics

PPD Operating Metrics

FY, 2018Q1, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020FY, 2020Q1, 2021Q2, 2021Q3, 2021

Backlog

$6.31 b$6.53 b$7.07 b$7.31 b$7.58 b$7.89 b$8.19 b$8.68 b$9.28 b$9.49 b

Clinical Trials

2.1 k

Countries

4646

Offices

100

PPD Acquisitions / Subsidiaries

Company NameDateDeal Size
Synarc Inc.September 03, 2019$45.2 m
Medimix InternationalJuly 01, 2019$36.8 m
Optimal ResearchSeptember 01, 2017$24 m
EvideraAugust 09, 2016
SynexusJune 06, 2016
X-ChemSeptember 26, 2014
RCT LogicSeptember 03, 2014
Bioduro-SundiaNovember 18, 2009
Excel PharmaStudiesOctober 01, 2009
AbCROApril 21, 2009
Show more

PPD Revenue Breakdown

Embed Graph

PPD revenue breakdown by geographic segment: 10.9% from Asia-Pacific, 56.5% from North America, 28.8% from Europe, Middle East and Africa and 3.8% from Other

Human Capital Metrics

Source: www.sec.gov
Embed Graph

PPD Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

PPD Online and Social Media Presence

Embed Graph

PPD Company Culture

  • Overall Culture

    C-

    62/100

  • CEO Rating

    C

    65/100

  • Compensation

    D+

    56/100

  • Diversity

    C-

    60/100

Learn more on Comparably

PPD News and Updates

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and...

Worldwide Preclinical CRO Industry to 2026 - Featuring Eurofins Scientific, MD Biosciences and PPD Among Others

Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global preclinical CRO market reached a value of US$ 4.6 Billion in 2020. Looking …

Society for Clinical Research Sites Names PPD Winner of Prestigious Eagle Award

PPD, Inc. (Nasdaq: PPD) is the recipient of the 2021 Eagle Award from the Society for Clinical Research Sites (SCRS) for its commitment to advancing clinical research professionalism through strong site partnerships.

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it has entered into an agreement with PPD, Inc. (Nasdaq: PPD), a leading global contract research organization (CRO), for PPD to oversee the com…

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

SAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it has entered into an agreement with PPD, Inc. (Nasdaq: PPD), a leading global contract...

City of Pleasanton will pay $5.9 million and allows grieving Parents of mentally ill man killed by Pleasanton Police to meet with the PPD Chief to discuss and implement policy changes.

OAKLAND, Calif., Aug. 10, 2021 /PRNewswire/ -- The City of Pleasanton has settled the wrongful death case of John and Rose Bauer v. City of Pleasanton, et al for $5.9 million, one of the largest settlements of its kind in the greater San Francisco Bay Area. The settlement is unusual in...
Show more

PPD Blogs

Three Ways to Drive Vaccine Trials Through Integrated Clinical Development and Laboratory Services

Discover three advantages of working with contract research organizations that have integrated clinical development and laboratory services. The post Three Ways to Drive Vaccine Trials Through Integrated Clinical Development and Laboratory Services appeared first on PPD Inc.

The Complementary Roles of Wearables and Patient-Reported Outcomes in Patient-Focused Drug Development: Spotlight on Oncology Trials

Researchers incorporating wearables into their work should think of them as complementing — rather than replacing — insights from PROs. The post The Complementary Roles of Wearables and Patient-Reported Outcomes in Patient-Focused Drug Development: Spotlight on Oncology Trials appeared first on PPD …

Four Key Attributes of Contract Chemistry Manufacturing and Controls (CMC) Labs

Good contract GMP labs become great and provide drug developers an edge when they demonstrate four key attributes. The post Four Key Attributes of Contract Chemistry Manufacturing and Controls (CMC) Labs appeared first on PPD Inc.

Closing the Gender Gap in Clinical Research

Discover how an in-depth understanding of women’s health can inform new solutions that close the gender gap in clinical research. The post Closing the Gender Gap in Clinical Research appeared first on PPD Inc.

Understanding Extractables and Leachables Testing and Analysis

Our experts provide an overview of extractables and leachables and explain their importance in the biopharmaceutical development process. The post Understanding Extractables and Leachables Testing and Analysis appeared first on PPD Inc.

The Growing Role of CROs in Clinical Trials

Our experts outline four key factors drug developers should consider when selecting a contract research organization (CRO) partner. The post The Growing Role of CROs in Clinical Trials appeared first on PPD Inc.
Show more

PPD Frequently Asked Questions

  • When was PPD founded?

    PPD was founded in 1985.

  • Who are PPD key executives?

    PPD's key executives are Rob Petrie, David Johnston and Amber Lee.

  • How many employees does PPD have?

    PPD has 27,655 employees.

  • What is PPD revenue?

    Latest PPD annual revenue is $4.7 b.

  • What is PPD revenue per employee?

    Latest PPD revenue per employee is $169.3 k.

  • Who are PPD competitors?

    Competitors of PPD include Eurofins, Parexel International and PRA Health Sciences.

  • Where is PPD headquarters?

    PPD headquarters is located at PPD Building, 929 N Front St, Wilmington.

  • Where are PPD offices?

    PPD has offices in Wilmington, Austin, Hamilton Township, Highland Heights and in 65 other locations.

  • How many offices does PPD have?

    PPD has 75 offices.